Table 1.
Laboratory test results in the 5 included patients.
| Cases | Date | TT3 (0.92–2.79 nmol/L) | TT4 (58–146 nmol/L) | FT3 (3.5–6.5 pmol/L) | FT4 (11-23 pmol/L) | TSH (0.5–4.8mIU/L) | TRAb (<1.5 IU/L) | TPOAb (0-9 IU/mL) | TgAb (0-4 IU/mL) | Therapy | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | 2019.3.27 | 5.38 | 15.28 | 1.771 | Methimazole (Saizhi) 10 mg qd for 2 months | ||||||
| 2022.8.1 | 1.5 | 113.7 | 4.98 | 16.35 | 0.755 | 1,621 | 97.2 | ||||
| 2023.3.24 | 6.04 | 369.9 | 26.67 | 68.53 | <0.008 | 3.18 | 3477.6 | 73.4 | |||
| 2023.5.14 | 1.86 | 92.9 | 4.98 | 13.08 | <0.008 | ||||||
| 2023.7.21 | 2.15 | 120.70 | 6.02 | 17.67 | 0.017 | ||||||
| Case 2 | 2022.8.24 | 2.33 | 157.2 | 5.56 | 19.58 | 0.707 | 837.2 | 72.2 | Methimazole (Saizhi) 10 mg qd for 1 months | ||
| 2023.2.20 | 4.65 | 289.72 | 11.01 | 38.91 | 0.00 | 1.3 | |||||
| 2023.3.27 | 5.70 | 295.80 | 19.75 | 45.05 | <0.008 | 274 | |||||
| 2023.4.5 | 3.14 | 150.25 | 7.49 | 17.82 | 0.01 | ||||||
| 2023.5.30 | 1.78 | 95.24 | 5.11 | 11.11 | 0.01 | 314 | 1.2 | ||||
| 2023.6.16 | 1.67 | 90.85 | 4.66 | 8.79 | 1.45 | 223.50 | 0.70 | ||||
| 2023.6.27 | 18.05 | ||||||||||
| Case 3 | 2021.3.28 | 4.47 | 8.83 | 12.697 | Methimazole (Saizhi) 10 mg qd for 2 months | ||||||
| 2021.4.22 | 5.38 | 17.77 | 0.112 | ||||||||
| 2021.4.25 | 1.21 | 117.99 | 5.14 | 16 | 0.1 | ||||||
| 2021.5.24 | 5.20 | 14.32 | 0.037 | 1.32 | 31.4 | 1.4 | |||||
| 2021.6.12 | 5.00 | 14.50 | 0.025 | 1.12 | |||||||
| 2021.7.17 | 4.23 | 12.86 | 0.046 | 183.2 | 11.3 | ||||||
| 2021.8.19 | 135 | 96.78 | 3.92 | 12.75 | 0.812 | ||||||
| 2022.2.27 | 2.09 | 140.39 | 4.86 | 10.98 | 1.764 | ||||||
| 2022.5.7 | 2.12 | 127.04 | 4.03 | 10.09 | 1.704 | ||||||
| 2023.3.12 | 4.25 | 244.78 | 15.18 | 38.11 | 0.01 | 34.47 | 645.2 | 318 | |||
| 2023.4.30 | 2.43 | 133.0 | 6.98 | 17.5 | 0.039 | ||||||
| 2023.6.17 | 1.68 | 90.60 | 4.94 | 12.76 | 0.489 | ||||||
| Case 4 | 2020.9.6 | 1.11 | 91.13 | 3.99 | 20.80 | 0.63 | 61.4 | <0.9 | Levothyroxine 50 μg qd for 2 months | ||
| 2020.11.14 | 1.37 | 99.61 | 4.92 | 18.80 | 0.93 | 27.7 | <0.9 | ||||
| 2021.1.29 | 1.33 | 90.24 | 4.25 | 21.31 | 0.49 | 17.4 | <0.9 | ||||
| 2021.5.2 | 1.20 | 69.60 | 3.32 | 17.50 | 0.43 | 19.3 | <0.9 | ||||
| 2021.8.8 | 1.92 | 96.20 | 5.40 | 21.00 | <0.01 | 212 | 219 | ||||
| 2022.2.6 | 0.87 | 8.23 | 3.41 | 1.48 | 0.67 | 43 | <0.9 | ||||
| 2023.2.1 | 1.31 | 79.66 | 4.26 | 18.39 | 1.25 | 521.52 | 100.30 | ||||
| 2023.3.12 | 0.81 | 30.94 | 2.83 | 12.24 | 79.44 | 614.22 | 309.84 | ||||
| 2023.5.7 | 1.31 | 79.66 | 4.26 | 18.39 | 1.25 | 521.52 | 100.30 | ||||
| 2023.6.26 | 1.41 | 87.50 | 3.40 | 17.00 | 1.07 | 85.90 | 34.70 | ||||
| Case 5 | 2018.3.15 | 4.94 | 10.16 | 1.62 | Methimazole (Saizhi) 10 mg qd for 1 months | ||||||
| 2023.2.14 | 2.27 | 211.86 | 2.27 | 33.49 | 0 | <0.25 | 21 | 2.2 | |||
| 2023.3.2 | 1.4 | 158.61 | 6.95 | 19.47 | 0 | ||||||
| 2023.3.16 | 1.08 | 135.61 | 6.44 | 13.58 | 0.01 | ||||||
| 2023.3.22 | 10.8 | 114.05 | 4.38 | 9.55 | 0.13 | ||||||
| 2023.4.19 | 1.07 | 92.21 | 5.37 | 10.60 | 3.73 | ||||||
| 2023.5.22 | 1.03 | 97.80 | 5.04 | 10.97 | 3.6 | 56.2 | 2.2 |
The test data highlighted in red show above-normal, while blue show below-normal.TT3, Total triiodothyronine; TT4, Serum total thyroxine; FT3, Free triiodothyronine; FT4, Free thyroxine; TSH, Thyroid stimulating hormone; TPOAb, Anti-thyroid peroxidase antibody; TgAb, Thyroglobulin antibody; TRAb, TSH receptor antibody.